Recommendation ID
NG101/12
Question

What is the effectiveness of vascularised lymph node transfer during axillary lymph node dissection for reducing the risk of secondary lymphoedema, and what is the acceptability of the intervention for different groups, such as:

Any explanatory notes
(if applicable)

women, men, trans people and non-binary people

people from ethnic minority backgrounds

people with disabilities.


Source guidance details

Comes from guidance
Early and locally advanced breast cancer: diagnosis and management
Number
NG101
Date issued
July 2018

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 10/07/2025